| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q86UQ4 (ABCAD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ATP-binding cassette sub-family A member 13; | |
| Q2M3G0 (ABCB5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ATP-binding cassette sub-family B member 5; ABCB5 P-gp; P-glycoprotein ABCB5; | |
| O60706 (ABCC9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ATP-binding cassette sub-family C member 9; Sulfonylurea receptor 2; | |
| P42684 (ABL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Tyrosine-protein kinase ABL2; Abelson murine leukemia viral oncogene homolog 2; Abelson tyrosine-protein kinase 2; Abelson-related gene protein; Tyrosine-protein kinase ARG; | |
| Q8N961 (ABTB2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ankyrin repeat and BTB/POZ domain-containing protein 2; | |
| A6QL63 (ABTB3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ankyrin repeat and BTB/POZ domain-containing protein 3; BTB/POZ domain-containing protein 11; | |
| O00763 (ACACB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Acetyl-CoA carboxylase 2; ACC-beta; | |
| Q6JQN1 (ACD10_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Acyl-CoA dehydrogenase family member 10; | |
| Q9UKV3 (ACINU_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Apoptotic chromatin condensation inducer in the nucleus; | |
| P53396 (ACLY_HUMAN) | Swiss-Prot | Homo sapiens (Human) | ATP-citrate synthase; ATP-citrate (pro-S-)-lyase; Citrate cleavage enzyme; | |
| Q4L235 (ACSF4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Beta-alanine-activating enzyme; Acyl-CoA synthetase family member 4; Protein NRPS998; | |
| Q08828 (ADCY1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylate cyclase type 1; ATP pyrophosphate-lyase 1; Adenylate cyclase type I; Adenylyl cyclase 1; Ca(2+)/calmodulin-activated adenylyl cyclase; | |
| Q08462 (ADCY2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylate cyclase type 2; ATP pyrophosphate-lyase 2; Adenylate cyclase type II; Adenylyl cyclase 2; | |
| O60266 (ADCY3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylate cyclase type 3; ATP pyrophosphate-lyase 3; Adenylate cyclase type III; Adenylate cyclase, olfactive type; Adenylyl cyclase 3; | |
| O95622 (ADCY5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylate cyclase type 5; ATP pyrophosphate-lyase 5; Adenylate cyclase type V; Adenylyl cyclase 5; | |
| P40145 (ADCY8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylate cyclase type 8; ATP pyrophosphate-lyase 8; Adenylate cyclase type VIII; Adenylyl cyclase 8; Ca(2+)/calmodulin-activated adenylyl cyclase; | |
| O60503 (ADCY9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adenylate cyclase type 9; ATP pyrophosphate-lyase 9; Adenylate cyclase type IX; Adenylyl cyclase 9; | |
| Q8N7X0 (ADGB_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Androglobin; | |
| Q6IQ32 (ADNP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Activity-dependent neuroprotector homeobox protein 2; Zinc finger protein 508; | |
| Q8IUX7 (AEBP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adipocyte enhancer-binding protein 1; Aortic carboxypeptidase-like protein; | |
| Q6UXC1 (AEGP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Apical endosomal glycoprotein; MAM domain-containing protein 4; | |
| P55198 (AF17_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein AF-17; ALL1-fused gene from chromosome 17 protein; | |
| P55196 (AFAD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Afadin; ALL1-fused gene from chromosome 6 protein; Afadin adherens junction formation factor; | |
| P51825 (AFF1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | AF4/FMR2 family member 1; ALL1-fused gene from chromosome 4 protein; Protein FEL; Proto-oncogene AF4; | |
| P51816 (AFF2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | AF4/FMR2 family member 2; Protein FMR-2; Protein Ox19; | |
| P51826 (AFF3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | AF4/FMR2 family member 3; Lymphoid nuclear protein related to AF4; | |
| Q99490 (AGAP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2; Centaurin-gamma-1; GTP-binding and GTPase-activating protein 2; Phosphatidylinositol 3-kinase enhancer; | |
| Q96PE1 (AGRA2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor A2; G-protein coupled receptor 124; Tumor endothelial marker 5; | |
| Q8IWK6 (AGRA3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor A3; G-protein coupled receptor 125; | |
| O14514 (AGRB1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor B1; Brain-specific angiogenesis inhibitor 1; Vasculostatin-40; Vstat40; Vasculostatin-120; Vstat120; | |
| O60241 (AGRB2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor B2; Brain-specific angiogenesis inhibitor 2; | |
| O60242 (AGRB3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor B3; Brain-specific angiogenesis inhibitor 3; | |
| Q8IZF2 (AGRF5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor F5; G-protein coupled receptor 116; | |
| Q8IZP9 (AGRG2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G-protein coupled receptor G2; G-protein coupled receptor 64; Human epididymis-specific protein 6; | |
| O94910 (AGRL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor L1; Calcium-independent alpha-latrotoxin receptor 1; Latrophilin-1; Lectomedin-2; | |
| O95490 (AGRL2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G protein-coupled receptor L2; Calcium-independent alpha-latrotoxin receptor 2; Latrophilin homolog 1; Latrophilin-2; Lectomedin-1; | |
| Q8WXG9 (AGRV1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Adhesion G-protein coupled receptor V1; G-protein coupled receptor 98; Monogenic audiogenic seizure susceptibility protein 1 homolog; Usher syndrome type-2C protein; Very large G-protein coupled receptor 1; ADGRV1 subunit alpha; ADGRV1 subunit beta; | |
| Q5TGY3 (AHDC1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor Gibbin; AT-hook DNA-binding motif-containing protein 1; | |
| Q8N157 (AHI1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Jouberin; Abelson helper integration site 1 protein homolog; | |
| Q8IVF2 (AHNK2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein AHNAK2; | |
| Q09666 (AHNK_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Neuroblast differentiation-associated protein AHNAK; Desmoyokin; | |
| Q99996 (AKAP9_HUMAN) | Swiss-Prot | Homo sapiens (Human) | A-kinase anchor protein 9; A-kinase anchor protein 350 kDa; A-kinase anchor protein 450 kDa; AKAP 120-like protein; Centrosome- and Golgi-localized PKN-associated protein; Protein hyperion; Protein kinase A-anchoring protein 9; Protein yotiao; | |
| Q9P2G1 (AKIB1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ankyrin repeat and IBR domain-containing protein 1; | |
| Q7Z591 (AKNA_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Microtubule organization protein AKNA; AT-hook-containing transcription factor; | |
| Q12802 (AKP13_HUMAN) | Swiss-Prot | Homo sapiens (Human) | A-kinase anchor protein 13; AKAP-Lbc; Breast cancer nuclear receptor-binding auxiliary protein; Guanine nucleotide exchange factor Lbc; Human thyroid-anchoring protein 31; Lymphoid blast crisis oncogene; Non-oncogenic Rho GTPase-specific GTP exchange factor; Protein kinase A-anchoring protein 13; p47; | |
| Q9NP73 (ALG13_HUMAN) | Swiss-Prot | Homo sapiens (Human) | UDP-N-acetylglucosamine transferase subunit ALG13; Asparagine-linked glycosylation 13 homolog; Glycosyltransferase 28 domain-containing protein 1; | |
| Q96QP1 (ALPK1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-protein kinase 1; Chromosome 4 kinase; Lymphocyte alpha-protein kinase; | |
| Q86TB3 (ALPK2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-protein kinase 2; Heart alpha-protein kinase; | |
| Q96L96 (ALPK3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alpha-protein kinase 3; Muscle alpha-protein kinase; | |
| Q96Q42 (ALS2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Alsin; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein; Amyotrophic lateral sclerosis 2 protein; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_05 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,656 | 17,497 | 43,444 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 26-mer | 32-mer | 36-mer | 39-mer | 40-mer | 46-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39,598 | 2,750 | 272 | 492 | 44 | 98 | 14 | 44 | 4 | 14 | 4 | 42 | 1 | 3 | 12 | 4 | 1 | 1 | 1 | 16 | 1 | 1 | 1 | 2 | 5 | 1 | 2 | 2 | 4 | 8 | 2 |